Desloratadine

Sold as Deselex, Neoclarityne, Neoloridin, Arydese, Dazit, Desodene, Desaway, Pollentyme nd, Clarex, Deslomed, Cipla desloratadine, Loralex, Acuhist, Dehrin, Austell desloratadine, Aerzit, Desloratadine unimed, Deseneeze, Neoscend, Neoscend odt, Lornid, Neoweez, Desotab, Deraliqe, Avarinex, Pollentyme fc, Demiltix, Deslotaz

C₁₉H₁₉ClN₂310.80 g/mol

13-Chloro-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene

Drag to rotate. Structure from PubChem CID 124087.

Loading Wikipedia summary

Registration

Applicants: 17
Registrations: 35
Schedule source: Consolidated Schedules 06 July 2026

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Bayer (Pty) Ltd û Isando	Deselex, Neoclarityne	tablets, syrup, 2,5 mg, 5 mg	350207, 350208, 370226, 370227, 430393, 430394	S2	None
Zydus Healthcare (Pty) Ltd	Neoloridin, Arydese, Desotab	2,5, 5	410214, 410226, 550305, 550306.305	S2	None
Ranbaxy Pharmaceutical (Pty) LtdCertificate held by Ranbaxy Pharmaceuticals (Pty) Ltd	Dazit, Deslotaz	2,5 mg, 5 mg	410448, 570264, 590767	S2	PI PIL
Dr Reddyæs Laboratories (Pty) LtdCertificate held by Dr. Reddy’s Laboratories (Pty) Ltd.1 of 2 cancelled	Desodene, Desaway	5 mg	410779, 420635	S2	PI
Astral Pharma (Pty) Ltd	Pollentyme nd, Pollentyme fc	5 mg	420849, 570363	S2	PI PIL
Unicorn Pharmaceuticals (Pty) Ltd	Clarex	5	420985	S2	None
Adcock ingram limited	Deslomed, Demiltix	2.5 mg, 5 ml	430079, 590453	S2	PI PIL
Cipla Medpro (Pty) LtdCancelled	Cipla desloratadine, Loralex	Not stated	431149, 431150	S2	None
Teva Pharmaceuticals (Pty) LtdCertificate held by Actavis Pharma (Pty) LtdCancelled	Acuhist	5 mg	450795	S2	PI PIL
Abex Pharmaceutica (Pty) Ltd	Dehrin	2,5 mg	460004	S2	PI PIL
Camox Pharmaceuticals (Pty) LtdCancelled	Austell desloratadine	5 mg	460492	S2	None
Austell Pharmaceuticals (Pty) Ltd	Aerzit	5	460493	S2	None
Unimed Healthcare (Pty) Ltd	Desloratadine unimed	5	460503	S2	None
Pharmacare limited û woodmead	Deseneeze	2,5 mg/5 ml	460697	S2	None
Ascendis Pharma (Pty) Ltd	Neoscend, Neoscend odt, Lornid, Neoweez	2,5, 5	500130, 500251, 500252, 500253, 500499	S2	None
Pharmacorp (Pty) Ltd	Deraliqe	Not stated	560532	S2	None
Innovata pharmaceuticals	Avarinex	2.5 mg	570168	S2	PI PIL

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Deselex tablets EACH TABLET CONTAINS DESLORATADINE 5,0 mg	Tablets	35020735/5.7.1/0207	Registered	S2	None
Neoclarityne tablets EACH TABLET CONTAINS DESLORATADINE 5,0 mg	Tablets	35020835/5.7.1/0208	Registered	S2	None
Neoclarityne syrup EACH 5,0 ml SYRUP CONTAINS DESLORATADINE 2,5 mg	Syrup	37022637/5.7.1/0226	Registered	S2	None
Deselex syrup EACH 5,0 ml SYRUP CONTAINS DESLORATADINE 2,5 mg	Syrup	37022737/5.7.1/0227	Registered	S2	None
Neoloridin 5 EACH TABLET CONTAINS DESLORATADINE 5,0 mg	5	41021441/5.7.1/0214	Registered	S2	None
Arydese 5 EACH TABLET CONTAINS DESLORATADINE 5,0 mg	5	41022641/5.7.1/0226	Registered	S2	None
Dazit tablets EACH TABLET CONTAINS DESLORATADINE 5,0 mg	5 mgFilm-coated tablet	41044841/5.7.1/0448Approved 1 December 2021	Registered	S2	PI PIL
Desodene EACH TABLET CONTAINS DESLORATADINE 5,0 mg	5 mg.Tablets	41077941/5.7.1/0779Approved 15 April 2020	Cancelled	S2	PI
Desaway EACH TABLET CONTAINS DESLORATADINE 5,0 mg	Not listed	42063542/5.7.1/0635	Registered	S2	None
Pollentyme nd EACH TABLET CONTAINS :DESLORATADINE 5,0 mg	Not listed	42084942/5.7.1/0849	Registered	S2	None
Clarex 5 EACH TABLET CONTAINS DESLORATADINE 5,0 mg	5	42098542/5.7.1/0985	Registered	S2	None
Deslomed syrup EACH 5,0 ml SYRUP CONTAINS DESLORATADINE 2,5 mg	2.5 mgSyrup	43007943/5.7.1/0079Approved 12 September 2025	Registered	S2	PI PIL
Deselex 2,5 MG EACH TABLET CONTAINS DESLORATADINE 2,5 mg	2,5 mg	43039343/5.7.1/0393	Registered	S2	None
Deselex 5 MG EACH TABLET CONTAINS DESLORATADINE 5,0 mg	5 mg	43039443/5.7.1/0394	Registered	S2	None
Cipla desloratadine EACH TABLET CONTAINS DESLORATADINE 5,0 mg	Not listed	43114943/5.7.1/1149	Cancelled	S2	None
Loralex EACH TABLET CONTAINS DESLORATADINE 5,0 mg	Not listed	43115043/5.7.1/1150	Cancelled	S2	None
Acuhist EACH TABLET CONTAINS DESLORATADINE 5,0 mg	5 mgFilm-coated tablet	45079545/5.7.1/0795Approved 20 April 2015	Cancelled	S2	PI PIL
Dehrin solution EACH 5,0 ml CONTAINS :DESLORATADINE 2,5 mg	2,5 mgOral solution	46000446/5.7.1/0004Approved 12 March 2025	Registered	S2	PI PIL
Austell desloratadine 5 MG EACH TABLET CONTAINS DESLORATADINE 5,0 mg	5 mg	46049246/5.7.1/0492	Cancelled	S2	None
Aerzit 5 EACH TABLET CONTAINS DESLORATADINE 5,0 mg	5	46049346/5.7.1/0493	Registered	S2	None
Desloratadine 5 unimed EACH TABLET CONTAINS DESLORATADINE 5,0 mg	5	46050346/5.7.1/0503	Registered	S2	None
Deseneeze syrup 2,5 mg/5 ML EACH 5,0 ml SOLUTION CONTAINS DESLORATADINE 2,5 mg	2,5 mg/5 mlSyrup	46069746/5.7.1/0697	Registered	S2	None
Neoscend 5 Each tablet contains DESLORATADINE 5,0 mg	5	50013050/5.7.1/0130	Registered	S2	None
Neoscend 2,5 odt Each tablet contains DESLORATADINE 2.5 mg	2,5	50025150/5.7.1/0251	Registered	S2	None
Neoscend 5 odt Each tablet contains DESLORATADINE 5,0 mg	5	50025250/5.7.1/0252	Registered	S2	None
Lornid Each 5 ml contains DESLORATADINE 2,5 mg	Not listed	50025350/5.7.1/0253	Registered	S2	None
Neoweez Each 5 ml contains DESLORATADINE 2,5 mg	Not listed	50049950/5.7.1/0499	Registered	S2	None
Neoloridin 2,5 EACH TABLET CONTAINS DESLORATADINE 2,5 mg	2,5	55030555/5.7.1/0305	Registered	S2	None
Desotab 2,5 EACH TABLET CONTAINS DESLORATADINE 2,5 mg	2,5	550306.30555/5.7.1/0306.305	Registered	S2	None
Deraliqe EACH TABLET CONTAINS DESLORATADINE 5,0 mg	Not listed	56053256/5.7.1/0532	Old Medicine	S2	None
Avarinex syrup EACH 5,0 ml SYRUP CONTAINS DESLORATADINE 2,5 mg	2.5 mgSyrup	57016857/5.7.1/0168Approved 5 August 2025	Registered	S2	PI PIL
Dazit syrup EACH 5,0 ml SOLUTION CONTAINS DESLORATADINE 2,5 mg	2,5 mgOral solution	57026457/5.7.1/0264Approved 16 May 2023	Registered	S2	PI PIL
Pollentyme fc Each Tablet contains: Desloratadine 5,0 mg	5 mgFilm coated tablets	57036357/5.7.1/0363Approved 10 June 2025	Registered	S2	PI PIL
Demiltix EACH 5,0 ml SYRUP CONTAINS DESLORATADINE 2,5 mg	5 mlSyrup	59045359/5.7.1/0453Approved 12 September 2025	Registered	S2	PI PIL
Deslotaz EACH TABLET CONTAINS DESLORATADINE 5,0 mg	Not listed	59076759/5.7.1/0767	Registered	S2	None

Regulatory status

Where S2 sits on the scale

S0S1S2S3S4S5S6S7S8

A pharmacist can sell it directly, without a prescription.

Schedule 2 medicines sit behind the pharmacy counter. A pharmacist can decide to sell one of these directly, using their own professional judgement, without a doctor's prescription. It can also be dispensed against a prescription like the higher tiers, in which case the usual repeat limits apply. A child under 12 may only be sold a Schedule 2 substance on a prescription, or on a written order that names the purpose and carries a signature the seller recognises. Even though it cannot be advertised to the public in the ordinary sense, its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S2, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: Only a pharmacist, pharmacist intern or supervised pharmacist's assistant may sell it without a prescription. It may otherwise be dispensed by a pharmacist against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Desloratadine

S2: Desloratadine
Consolidated Schedules 06 July 2026, line 1797

Pharmacological class: Antihistaminics. (class 5.7.1)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

Dazit tablets, Ranbaxy Pharmaceutical (Pty) Ltd is scheduled S2 in its official SAHPRA documents, read with 90% confidence.

Professional information (PI)For healthcare professionalsDazit tablets, Ranbaxy Pharmaceutical (Pty) Ltd Patient information leaflet (PIL)For patients and carersDazit tablets, Ranbaxy Pharmaceutical (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles

Background